Merck KGaA, Institute of Cancer Research, Wellcome Trust deal

Merck’s Merck Serono S.A. unit, The Institute of Cancer Research and the Wellcome Trust partnered to identify and develop tankyrase TRF1-interacting ankyrin-related ADP-ribose polymerase (TNKS) inhi...